Results 131 to 140 of about 2,602 (175)

Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure. [PDF]

Clin Exp Hepatol, 2023
Tronina O, Brzdęk M, Zarębska-Michaluk D, Lorenc B, Janocha-Litwin J, Berak H, Sitko M, Dybowska D, Mazur W, Tudrujek-Zdunek M, Janczewska E, Klapaczyński J, Dobracki W, Parfieniuk-Kowerda A, Krygier R, Socha Ł, Flisiak R.   +16 more
europepmc   +1 more source

Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes. [PDF]

Sci Rep
Brzdęk M, Zarębska-Michaluk D, Rzymski P, Lorenc B, Janocha-Litwin J, Berak H, Tomasiewicz K, Sitko M, Mazur W, Janczewska E, Dybowska D, Klapaczyński J, Parfieniuk-Kowerda A, Jaroszewicz J, Piekarska A, Flisiak R.   +15 more
europepmc   +1 more source

Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET^® Medical Information Database Network in Japan. [PDF]

Ther Innov Regul Sci, 2022
Hasegawa T, Sawada S, Ishiguro C, Ando T, Kobayashi K, Komiyama N, Iguchi T, Nonaka T, Uyama Y.   +8 more
europepmc   +1 more source

Hepatitis C: current treatments, emerging therapies and tackling health inequities on the path to global elimination. [PDF]

Clin Med (Lond)
Farooq HZ, Foster GR.
europepmc   +1 more source

A novel scoring system to identify patients at low risk for hepatocellular carcinoma five years after DAA-Induced sustained virological response: a retrospective cohort study. [PDF]

BMC Gastroenterol
Fujii H, Nishimura T, Kimura H, Mitsumoto Y, Shima T, Seko Y, Moriguchi M, Kataoka S, Tanaka S, Ishikawa H, Takami S, Nagao Y, Umemura A, Itoh Y, Yamaguchi K.   +14 more
europepmc   +1 more source

A Synopsis of Hepatitis C Virus Treatments and Future Perspectives. [PDF]

Curr Issues Mol Biol, 2023
Medina C, García AH, Crespo FI, Toro FI, Mayora SJ, De Sanctis JB.   +5 more
europepmc   +1 more source

Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study. [PDF]

Sci Rep
Vats P, Rolta R, Salaria D, Sharma I, Verma A, Fadare OA, Verma M.   +6 more
europepmc   +1 more source

HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation. [PDF]

Drug Metab Dispos
Work HM, Hackett JC, Lampe JN.
europepmc   +1 more source

Real-World Treatment Efficacy and Safety Profile of Sofosbuvir- and Velpatasvir-Based HCV Treatment in South Korea: Multicenter Prospective Study. [PDF]

Viruses
Yoon JH, Lee CH, Jo HG, Cho JY, Kim JD, Kim JW, You GR, Cho SB, Choi SK.   +8 more
europepmc   +1 more source

Precision spatiotemporal analysis of large-scale compound-protein interactions through molecular dynamics simulation. [PDF]

PNAS Nexus
Matsumoto S, Isaka Y, Kanada R, Ma B, Araki M, Chiba S, Tokuhisa A, Iwata H, Ishida S, Akinaga Y, Terayama K, Kojima R, Harada Y, Takemura K, Honma T, Kitao A, Okuno Y.   +16 more
europepmc   +1 more source